RNA
USDAvidity Biosciences Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$69.780
고가
$69.870
저가
$69.760
거래량
7.06M
기업 기본 정보
시가총액
10.3B
산업
생명공학
국가
United States
거래 통계
평균 거래량
5.20M
거래소
NGM
통화
USD
52주 범위
관련 뉴스
Halper Sadeh LLC Encourages RNA, JAMF, AWK Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
TD Cowen Downgrades Avidity Biosciences to Hold, Lowers Price Target to $74
TD Cowen analyst Ritu Baral downgrades Avidity Biosciences from Buy to Hold and lowers the price target from $78 to $74.
Shareholder Alert: The Ademi Firm investigates whether Avidity Biosciences Inc. is obtaining a Fair Price for its Public Shareholders
The Ademi Firm is investigating Avidity (Nasdaq: RNA) for possible breaches of fiduciary duty and other violations of law in its transaction with...
Chardan Capital Downgrades Avidity Biosciences to Neutral, Lowers Price Target to $72
Chardan Capital analyst Keay Nakae downgrades Avidity Biosciences from Buy to Neutral and lowers the price target from $75 to $72.
RBC Capital Downgrades Avidity Biosciences to Sector Perform, Raises Price Target to $72
RBC Capital analyst Luca Issi downgrades Avidity Biosciences from Outperform to Sector Perform and raises the price target from $61 to $72.
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avidity Biosciences, Inc. (NASDAQ: RNA)
Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...
Avidity Biosciences Soars After $72 Per Share Novartis Takeover
Avidity Biosciences to be acquired by Novartis in a $12 billion cash deal. H.C. Wainwright downgrades to Neutral.
